FDA Authorized COVID Drugs Get New Advertising Abilities, Likely Necessitated By First Amendment
Executive Summary
Pfizer and Merck indicate they may take advantage of new FDA decision that will give companies more flexibility to tout clinical trial results of COVID-19 therapeutics granted emergency use authorization.